Bibi Petersen, Henrik Lorentzen. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » AdultAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedCytomegalovirus/immunologyCytomegalovirus Infections/complicationsEtanerceptFemaleHumansImmunoglobulin G/bloodImmunoglobulin G/therapeutic useImmunoglobulin M/bloodImmunosuppressive Agents/therapeutic useMaleMiddle AgedOpportunistic Infections/complicationsPsoriasis/drug therapyReceptors, Tumor Necrosis Factor/therapeutic useTumor Necrosis Factor-alpha/antagonists & inhibitors
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedImmunoglobulin GImmunoglobulin MImmunosuppressive AgentsReceptors, Tumor Necrosis FactorTumor Necrosis Factor-alphaEtanerceptefalizumab
Year: 2008 PMID: 18779901 DOI: 10.2340/00015555-0491
Source DB: PubMed Journal: Acta Derm Venereol ISSN: 0001-5555 Impact factor: 4.437